Search
for
Sort by
Research 571–600 of 1000+
- Festschrift in honor of the 65th birthday of Dr. Howard I. Maibach
- Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity
- Alopecia areata: An individualized homeopathic journey from suffering to stability at Dr Batra’s
- DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS
- A retrospective analysis of dermatoses in the perimenopausal population attending a tertiary care centre in South India
- A study of COVID‐19 vaccine (Covishield) induced dermatological adverse effects from India
- Epidemiological profile of patients presenting to dermatology department of a tertiary care hospital during nationwide lockdown due to COVID-19: a retrospective study from north India
- STUDY OF CUTANEOUS MANIFESTATIONS IN THYROID DISORDERS
- 41761 Alpha-gal Syndrome for the Dermatologist
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Skin amidst COVID ‐19 pandemic
- Dermatological Manifestations of COVID-19: A Comprehensive Review
- Stem-cell therapy in dermatology – Challenges and opportunities
- Hypersensitivity to intravenous ondansetron: a case report
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Comorbidities in Dermatology
- Cutaneous Manifestations of COVID-19
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- MANIFESTAÇÕES CUTÂNEAS CORROBORADAS À INFECÇÃO POR SARS-COV-2
- 104 Willingness-to-pay of patients with chronic skin diseases: A pilot study
- Questions and Answers
- The Scientific Legacy of Stephen Rothman
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Anticonvulsant-Induced Cutaneous Reactions
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database